Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

[Lynch syndrome: case report and review of the literature].

Bouguenouch L, Samri I, Belhassan K, Sayel H, Abbassi M, Bennis S, Benajah DA, Ibrahimi A, Amarti A, Ouldim K.

Pan Afr Med J. 2016 Jun 14;24:142. doi: 10.11604/pamj.2016.24.142.4398. eCollection 2016. Review. French.

2.

Next-generation sequencing for genetic testing of familial colorectal cancer syndromes.

Simbolo M, Mafficini A, Agostini M, Pedrazzani C, Bedin C, Urso ED, Nitti D, Turri G, Scardoni M, Fassan M, Scarpa A.

Hered Cancer Clin Pract. 2015 Aug 21;13(1):18. doi: 10.1186/s13053-015-0039-9. eCollection 2015.

3.

Risk of breast cancer in Lynch syndrome: a systematic review.

Win AK, Lindor NM, Jenkins MA.

Breast Cancer Res. 2013 Mar 19;15(2):R27. doi: 10.1186/bcr3405. Review.

4.

Epidemiology of cancer of the small intestine.

Pan SY, Morrison H.

World J Gastrointest Oncol. 2011 Mar 15;3(3):33-42. doi: 10.4251/wjgo.v3.i3.33.

5.

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.

van der Post RS, Kiemeney LA, Ligtenberg MJ, Witjes JA, Hulsbergen-van de Kaa CA, Bodmer D, Schaap L, Kets CM, van Krieken JH, Hoogerbrugge N.

J Med Genet. 2010 Jul;47(7):464-70. doi: 10.1136/jmg.2010.076992.

6.

Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.

Olschwang S, Yu K, Lasset C, Baert-Desurmont S, Buisine MP, Wang Q, Hutter P, Rouleau E, Caron O, Bourdon V, Thomas G.

J Cancer Epidemiol. 2009;2009:791754. doi: 10.1155/2009/791754. Epub 2009 Mar 8.

7.

Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.

Kopciuk KA, Choi YH, Parkhomenko E, Parfrey P, McLaughlin J, Green J, Briollais L.

Hered Cancer Clin Pract. 2009 Oct 28;7(1):16. doi: 10.1186/1897-4287-7-16.

8.

Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.

Choi YH, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, Gallinger S, McLaughlin J, Aronson M, Briollais L.

Hered Cancer Clin Pract. 2009 Aug 23;7(1):14. doi: 10.1186/1897-4287-7-14.

9.

Is surveillance of the small bowel indicated for Lynch syndrome families?

ten Kate GL, Kleibeuker JH, Nagengast FM, Craanen M, Cats A, Menko FH, Vasen HF.

Gut. 2007 Sep;56(9):1198-201. Epub 2007 Apr 4.

10.

Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression.

Halvarsson B, Müller W, Planck M, Benoni AC, Mangell P, Ottosson J, Hallén M, Isinger A, Nilbert M.

J Clin Pathol. 2007 Jul;60(7):781-6. Epub 2006 Aug 10.

Supplemental Content

Support Center